Condition (MeSH)
Antisocial Personality Disorder
ClinicalTrials.gov lists 67 trials for Antisocial Personality Disorder or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
67 of the 67 trials are tagged with Antisocial Personality Disorder itself; the rest are tagged with a narrower condition beneath it.
When did Antisocial Personality Disorder trials start? (27)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 2 |
| 2024 | 3 |
| 2023 | 4 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 4 |
| 2019 | 3 |
| 2018 | 3 |
| 2017 | 6 |
Showing 10 of 27 earlier years.
No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 9 trials still running at the 2026-10-09 snapshot; registered median of 30 months across 39 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Antisocial Personality Disorder trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 2/3 | 5 |
| Phase 4 | 4 |
| Not applicable | 31 |
| Observational | 22 |
How many Antisocial Personality Disorder trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Completed | 39 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Antisocial Personality Disorder trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GE Healthcare | 3 |
| National Institute of Mental Health (NIMH) | 3 |
Which drugs are being tested for Antisocial Personality Disorder? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Naratriptan | 1 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Treatment As Usual | 6 |
| fatty acids, omega-3 | 2 |
| Cognitive Remediation | 2 |
| IM Oxytocin | 1 |
| Standard Care | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Antisocial Personality Disorder trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Premature delivery | 24 | 1 |
| Premature baby | 17 | 1 |
| Drug withdrawal syndrome neonatal | 9 | 1 |
| Death | 6 | 1 |
| Neonatal respiratory distress syndrome | 6 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Antisocial Personality Disorder? (154)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Psychopathy and dangerousness: An umbrella review and meta-analysis. | Clinical psychology review | 2023 | Yes |
| The efficacy of the PSYCHOPATHY.COMP program in reducing psychopathic traits: A controlled trial with male detained youth. | Journal of consulting and clinical psychology | 2021 | Yes |
| Psychopathy is associated with an exaggerated attention bottleneck: EEG and behavioral evidence from a dual-task paradigm. | Cognitive, affective & behavioral neuroscience | 2021 | Yes |
| Psychological interventions for antisocial personality disorder. | The Cochrane database of systematic reviews | 2020 | Yes |
| Pharmacological interventions for antisocial personality disorder. | The Cochrane database of systematic reviews | 2020 | Yes |
Showing 5 of 154 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.